In Vitro Efficacy Evaluation Service

The in vitro efficacy evaluation service of CellPurics is provided by expert researchers using state-of-the-art equipment to quickly
and accurately evaluate the safety and efficacy of test substances.
It provides customers with reliable data that they need for drug discovery and safety assessment.

• In Vitro Cancer Immunotherapy Efficacy
  Evaluation Service
• Cosmetic Efficacy Evaluation
• Mesenchymal Stem Cell Quality Testing Service

Anti-Cancer Cytotoxicity Test

This test assesses the toxicity of test substances to cancer cells to evaluate the efficacy of T cell- or NK cell-based cell therapeutics and antibody-based cancer immunotherapy

Complement-dependent Cell-Mediated Cytotoxicity (CDCC) Testing

Antibody-dependent Cell-mediated Cytotoxicity (ADCC) Testing

T cell-mediated tumor cell killing assays

NK cell-mediated tumor cell killing assays

Immune Cell Analysis

This test analyzes and quantifies the activity status of immune cells, the expression of functional proteins, and the degree of proliferation

Immune cell Characterization

Cell proliferation

Cytokine release

Activation marker expression

Exhaustion marker expression

Immune Cell Analysis

This test quantifies the extent to which cancer Immunotherapy acts on immune checkpoints

Co-inhibitory Bioassays
(PD-1, CTLA-4, LAG-3, TIGIT, CD226)

Co-stimulatory Bioassays
(GITR, 4-1BB, OX40, CD40,HVEM)

Combination Bioassay (PD-1+TIGIT)